Erratum to ‘Inhibition of ATGL alleviates MASH via impaired PPARa signalling that favours hydrophilic bile acid composition in mice’ [J Hepatol 82 (2025) 658–675]
Emmanuel D. Dixon(Medical University of Vienna), Michael Trauner(Medical University of Graz), Georg Busslinger(Austrian Academy of Sciences), Alexander D Nardo(Medical University of Vienna), G Grabner(University of Graz), Henkjan J. Verkade(Cystic Fibrosis Foundation), Hubert Scharnagl(Medical University of Graz), Guenter Haemmerle(University of Graz), Dagmar Kratky(Medical University of Graz), Thierry Claudel(Medical University of Vienna), Robert Zimmermann(BioTechMed-Graz), Veronika Mlitz(Medical University of Vienna), Alessandra Riva(University of Vienna), Helga Hinteregger(Medical University of Graz), Tatjana Stojaković, Claudia Fuchs(Medical University of Vienna), Joana Séneca(University of Vienna)
Cited by 0
Related Papers
Cardioprotection and lifespan extension by the natural polyamine spermidine
|Nature Medicine|2016|1.1k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399